ISB 1442

· Ichnos Sciences SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISB 1442, covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]